The inhibition of invasion by statins in the aggressive MDA-MB-231 triple-negative breast cancer cells has been attributed to the suppression of the RhoA/ROCK/NF-kB signaling pathway [65]. Here, NFKB1 is linked to triple-negative breast carcinoma.